reviews for glp-1 Lemme Daily Capsules Review: A Doctor's Honest Opinion GLP-1 Medications: What Employers Should
Description
Together with Ryan Livingston, we created a piece looking back at the 1-year implications of the GLP-1 antagonist for CKD and T2D, speaking with key experts from Cleveland Clinic and the American Heart Association, along with Holly Kramer from Loyola Medicine, Editor-in-Chief at Advances in Kidney Disease and Health (AKDH)
This is concerning
The peptide displayed a very good safety and tolerability profile indistinguishable from placebo, with no treatment-related serious adverse events or study withdrawals
How is that even possible
